FDA
approval
· 2016-12-16
FDA Approved: XTAMPZA ER — Supplemental Application (Collegium Pharmaceutical, Inc.)
Summary
The FDA approved a supplemental application for XTAMPZA ER (oxycodone) from Collegium Pharmaceutical, Inc., to modify the product labeling under the approved su…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for XTAMPZA ER (OXYCODONE)